UBS ASSET MANAGEMENT AMERICAS LLC - MAXCYTE INC ownership

MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 98 filers reported holding MAXCYTE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of MAXCYTE INC
ValueSharesWeighting
Q3 2023$461,628
+49.9%
147,958
+137.8%
0.00%
Q2 2023$307,9540.0%62,2130.0%0.00%
Q1 2023$307,954
-10.3%
62,213
-1.1%
0.00%
Q4 2022$343,434
-99.9%
62,9000.0%0.00%
Q3 2022$408,850,000
+37.4%
62,9000.0%0.00%
Q2 2022$297,517,000
-7.5%
62,900
+36.7%
0.00%
Q1 2022$321,540,000
-31.4%
46,0000.0%0.00%
Q4 2021$468,740,00046,0000.00%
Other shareholders
MAXCYTE INC shareholders Q1 2022
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 372,000$4,542,0004.32%
Casdin Capital, LLC 13,971,334$170,590,0004.25%
Montanaro Asset Management Ltd 2,549,000$30,996,0003.74%
HARBERT FUND ADVISORS, INC. 724,856$8,850,0003.14%
Nine Ten Capital Management LLC 1,900,968$23,211,0002.48%
RIVER GLOBAL INVESTORS LLP 2,305,500$27,978,0002.17%
Vitruvian Partners LLP 3,330,000$40,659,0001.70%
Nicholas Investment Partners, LP 980,122$11,967,0000.87%
First Light Asset Management, LLC 994,670$12,145,0000.80%
AREX Capital Management, LP 126,968$1,550,0000.72%
View complete list of MAXCYTE INC shareholders